Competitive Costs of Disclosure by Biotech IPOs
- 15 April 2004
- journal article
- Published by Wiley in Journal of Accounting Research
- Vol. 42 (2), 319-355
- https://doi.org/10.1111/j.1475-679x.2004.00140.x
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- The Quiet Period Goes out with a BangThe Journal of Finance, 2003
- Disclosure Choice and Cost of Capital: Evidence from Underpricing in Initial Public OfferingsSSRN Electronic Journal, 2002
- Discretionary Disclosure: A NoteAbacus, 2001
- Blockholder Ownership and Market LiquidityJournal of Financial and Quantitative Analysis, 2000
- The interaction between product market and financing strategy: The role of venture capitalThe Review of Financial Studies, 2000
- The Association between Competition and Managers' Business Segment Reporting DecisionsJournal of Accounting Research, 1998
- Industry costs of equityJournal of Financial Economics, 1997
- THE MARKET REWARDS PROMISING R&D—AND PUNISHES THE RESTJournal of Applied Corporate Finance, 1992
- Estimating the components of the bid/ask spreadJournal of Financial Economics, 1988
- Stock return variances: The arrival of information and the reaction of tradersJournal of Financial Economics, 1986